Issuu on Google+

Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Category: Healthcare

www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Report Details

• • • • • • • • •

Publish date: Jun 30, 2013 Number of slides: 131 Geographic coverage: India Available format: PDF, CD, Hardcopy Price for Single User License: USD 4,995 Price for Site License: USD 9,990 Price for Global User License: USD 14,985 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Report Coverage

• Overview of non-small cell lung cancer (NSCLC) including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape • Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis • Sales forecast for the top drugs in India from 2012-2022 • Analysis of the impact of key events as well the drivers and restraints affecting India NSCLC market www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Report Benefits

• Understand and capitalize by identifying products that are most likely to ensure a robust return • Stay ahead of the competition by understanding the changing competitive landscape for NSCLC • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential • Make more informed business decisions from insightful and in-depth analysis of drug performance • Obtain sales forecast for drugs from 2012-2022 in India www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Table of Contents

• Introduction • Disease Overview • Disease Management • Competitive Assessment • Opportunity and Unmet Need • Pipeline Assessment • Market Outlook • Appendix

www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 List of Figures and Tables

Figures: • Competitive Assessment of Late-Stage Pipeline Agents in NSCLC, 2012-2022 • Sales for NSCLC in India by Drug, 2012-2022

Tables: • • • • • • • • • •

Symptoms of Disease Treatment Guidelines for NSCLC Stage Definitions for NSCLC Treatment Overview by Stage of Diagnosis for NSCLC Leading Treatments for NSCLC Product Profile - Alimta (pemetrexed disodium) Alimta SWOT Analysis, 2013 Product Profile - Iressa (gefitinib) Iressa SWOT Analysis, 2013 Product Profile - Tarceva (erlotinib hydrochloride) www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 List of Figures and Tables (Continued)

• • • • • • • • • • • • • • • •

Tarceva SWOT Analysis, 2013 Product Profile - Xalkori (crizotinib) Xalkori SWOT Analysis, 2013 Product Profile - Avastin (bevacizumab) Avastin SWOT Analysis, 2013 Overall Unmet Needs - Current Level of Attainment Clinical Unmet Needs - Gap Analysis, 2013 Non-Small Cell Lung Cancer - Phase I-II Pipeline, 2013 NSCLC - Phase III Pipeline, 2013 NSCLC - Advantages and Disadvantages of Therapeutic Classes Product Profile - nintedanib (BIBF-1120) nintedanib SWOT Analysis, 2013 Product Profile - Gilotrif (afatinib) Gilotrif SWOT Analysis, 2013 Product Profile - dacomitinib (PF-00299804) dacomitinib SWOT Analysis, 2013 www.researchonglobalmarkets.com


Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 List of Figures and Tables (Continued)

• • • • • • • •

Product Profile - LDK378 LDK378 SWOT Analysis, 2013 Sales Forecasts ($m) for NSCLC in India, 2012-2022 Key Events Impacting Sales for NSCLC in India, 2012-2022 NSCLC Market in India - Drivers and Barriers, 2012-2022 Five Year Prevalence Key Launch Dates Physicians Surveyed by Country

www.researchonglobalmarkets.com


Interested in this report? To view more details regarding this premium market research report, Please click here

For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: International: +91 (22) 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport

Consumer goods

Agriculture

Food and Beverage

Energy and Utilities

Public Sector

Manufacturing & Construction

Healthcare

Media & Entertainment

IT, Telecom & Electronics

Services

Others

www.researchonglobalmarkets.com


India Market Research Report : Pharma point non small cell lung cancer